Want to join the conversation?
UBS analyst Brennan Hawken questions on $BAC's assumptions on legal and some market-sensitive businesses as expense line items there have a big impact from market conditions. CFO Paul Donofrio says that from a legal point of view, the company had $270MM in 2Q16. $BAC says that the $53Bil is absorbing increases in merit, healthcare & investment.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?